Marcus Buggert News Today

Two researchers at Karolinska Institutet have been awarded grants from the PolyBio Research Foundation totalling USD 1.85 million dollars (SEK 19 million) for research into long COVID. It is hoped that the studies will provide valuable insights that can promote the development of more efficacious treatments for long COVID, which is still a puzzling condition. Since the outbreak of the pandemic, Marcus Buggert and his group at Karolinska Institutet have studied the COVID-19 virus SARS-CoV-2 in or...

Scientists say some people may be resistant even if they haven’t had the new coronavirus

Mpox vaccines are so similar to the smallpox vaccine that a new study has found that smallpox vaccination provides some protection against mpox.

Vaccines against smallpox given until the mid-1970s offer continuing cross-reactive immunity to mpox (previously known as monkeypox), researchers from

Vaccines against smallpox given until the mid-1970s offer continuing cross-reactive immunity to mpox (previously known as monkeypox), researchers from Karolinska Institutet in Sweden report in a study published in the scientific journal Cell Host & Microbe.

During the COVID-19 pandemic, medical professionals and researchers observed that children and teenagers who contracted the virus exhibited milder symptoms compared to adults. This phenomenon may be attributed to the presence of memory T cells in children, which were generated as a result of previou

As people across the world grapple with the prospect of living with the coronavirus for the foreseeable future, one question looms large: How soon before they need yet another shot?

A fourth dose of a COVID vaccine may be unnecessary for most people, say a flurry of new studies.

As people around the world grapple with the prospect of living with the coronavirus for the foreseeable future, the question of when they need yet another shot looms large.

Follow the StarTribune for the news, photos and videos from the Twin Cities and beyond.